$369.84
-1.53-0.41%
In chiusura: -
$342.00
-27.84-7.53%
After hour: Aug 15, 6:59 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Madrigal Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 30
Stima EPS
$-3.599
Stima dei ricavi trimestrali
$181.21M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$515.55M
Analizza lo storico degli utili di Madrigal Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
MDGL | Madrigal Pharmaceuticals | -$4.92 | -$3.60 | — | — | $62.17M | $181.21M | — | — | 10/30/2025 | |
MDGL | Madrigal Pharmaceuticals | -$7.10 | -$3.74 | -$1.90 | 46.02% | $14.64M | $158.90M | $212.80M | 31.91% | 08/05/2025 | |
MDGL | Madrigal Pharmaceuticals | -$7.38 | -$3.69 | -$3.32 | 12.40% | $0.00 | $113.76M | $137.25M | 20.19% | 05/01/2025 | |
MDGL | Madrigal Pharmaceuticals | -$5.68 | -$4.24 | -$2.71 | 34.22% | $0.00 | $98.56M | $103.32M | 13.23% | 02/26/2025 | |
MDGL | Madrigal Pharmaceuticals | -$5.34 | -$6.93 | -$4.92 | 28.80% | $0.00 | $33.66M | $62.17M | 81.85% | 10/31/2024 | |
MDGL | Madrigal Pharmaceuticals | -$4.69 | -$7.53 | -$7.10 | 5.84% | $0.00 | $3.90M | $14.64M | 264.13% | 08/07/2024 | |
MDGL | Madrigal Pharmaceuticals | -$4.23 | -$6.28 | -$7.38 | -17.52% | $0.00 | — | $0.00 | — | 05/07/2024 | |
MDGL | Madrigal Pharmaceuticals | -$4.98 | -$5.28 | -$5.68 | -7.58% | $0.00 | — | $0.00 | — | 02/28/2024 | |
MDGL | Madrigal Pharmaceuticals | -$4.75 | -$4.92 | -$5.34 | -8.54% | $0.00 | — | $0.00 | — | 11/06/2023 | |
MDGL | Madrigal Pharmaceuticals | -$4.14 | -$4.58 | -$4.69 | -2.40% | $0.00 | — | $0.00 | — | 08/08/2023 | |
MDGL | Madrigal Pharmaceuticals | -$3.36 | -$4.94 | -$4.23 | 14.37% | $0.00 | — | $0.00 | — | 05/09/2023 | |
MDGL | Madrigal Pharmaceuticals | -$3.78 | -$4.56 | -$4.98 | -9.21% | $0.00 | — | $0.00 | — | 02/23/2023 | |
MDGL | Madrigal Pharmaceuticals | -$3.79 | -$4.15 | -$4.75 | -14.46% | $0.00 | — | $0.00 | — | 11/03/2022 | |
MDGL | Madrigal Pharmaceuticals | -$3.72 | -$3.75 | -$4.14 | -10.40% | $0.00 | — | $0.00 | — | 08/04/2022 | |
MDGL | Madrigal Pharmaceuticals | -$3.32 | -$3.62 | -$3.36 | 7.18% | $0.00 | — | $0.00 | — | 05/09/2022 | |
MDGL | Madrigal Pharmaceuticals | -$3.82 | -$3.88 | -$3.78 | 2.58% | $0.00 | — | $0.00 | — | 02/24/2022 | |
MDGL | Madrigal Pharmaceuticals | -$3.75 | -$3.90 | -$3.79 | 2.82% | $0.00 | — | $0.00 | — | 11/04/2021 | |
MDGL | Madrigal Pharmaceuticals | -$3.18 | -$3.59 | -$3.72 | -3.62% | $0.00 | — | $0.00 | — | 08/05/2021 | |
MDGL | Madrigal Pharmaceuticals | -$2.34 | -$3.85 | -$3.32 | 13.77% | $0.00 | — | $0.00 | — | 05/06/2021 | |
MDGL | Madrigal Pharmaceuticals | -$1.80 | — | -$3.82 | — | $0.00 | — | $0.00 | — | 02/25/2021 | |
MDGL | Madrigal Pharmaceuticals | -$1.39 | — | -$3.75 | — | $0.00 | — | $0.00 | — | 11/05/2020 |
Madrigal Pharmaceuticals (MDGL) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $-1.90 | $-3.74 | 46.0 % |
| Q1 | 2025-05-01 | $-3.32 | $-3.69 | 12.4 % |
| Q4 | 2025-02-26 | $-2.71 | $-4.24 | 34.2 % |
| Q3 | 2024-10-31 | $-4.92 | $-6.93 | 28.8 % |
Madrigal Pharmaceuticals (MDGL) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $212.80M | $158.90M | 31.9 % |
| Q1 | 2025-05-01 | $137.25M | $113.76M | 20.2 % |
| Q4 | 2025-02-26 | $103.32M | $98.56M | 13.2 % |
| Q3 | 2024-10-31 | $62.18M | $33.66M | 81.8 % |
FAQ
Quando Madrigal Pharmaceuticals (NASDAQ:MDGL) riporterà gli utili?
Si prevede che Madrigal Pharmaceuticals (MDGL) fornisca risultati il ottobre 30, 2025. Gli ultimi risultati sono stati pubblicati il agosto 5, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Madrigal Pharmaceuticals (NASDAQ:MDGL)?
L'EPS effettivo era $-1.90, che superato la stima di $-3.74.
Quali sono state le entrate di Madrigal Pharmaceuticals (NASDAQ:MDGL)?
Le entrate effettive sono state $212.8M, che superato la stima di $158.9M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.